Skip to main content
OpenTrials
Completed

NCT Number: NCT00002575

Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer

RATIONALE: Less invasive types of surgery may help reduce the number of side effects and improve recovery. It is not yet known which type of surgery is more effective for colon cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of laparoscopic-assisted colectomy with open colectomy in treating patients who have colon cancer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada

Loading trial locations.

About this study

OBJECTIVES:

  • Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy.
  • Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients.
  • Compare the differences in costs and cost effectiveness between these treatments in this patient population.
  • Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99)

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center, primary surgeon, site of primary tumor (right vs left vs sigmoid), and American Society of Anesthesiologists disease classification (I and II vs III). Patients are randomized to one of two treatment arms.

The extent of colon resection is identical for both arms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

DISEASE CHARACTERISTICS:

  • Clinical diagnosis of primary adenocarcinoma
  • Involving a single colon segment:
  • Right colon from the ileocecal valve up to and including the hepatic flexure
  • Left colon from the splenic flexure to the junction of the sigmoid and descending colon
  • Sigmoid colon between the descending colon and the rectum (at least 15 cm from the dentate)
  • Diagnosis based on physical exam plus either a proctosigmoidoscopy and barium enema or a colonoscopy
  • No advanced local disease that renders laparoscopic resection impossible
  • No acutely obstructed or perforated colon cancer requiring urgent surgery
  • No transverse colon cancer (i.e., between distal hepatic flexure and proximal splenic flexure)
  • No stage IV disease
  • No rectal cancer (i.e., below the peritoneal reflection, lower edge of tumor less than 15 cm from dentate)
  • No American Society of Anesthesiologists IV/V disease classification
  • No associated gastrointestinal diseases (i.e., Crohn's, chronic ulcerative colitis, or familial polyposis) that require additional extensive operative evaluation or intervention

PATIENT CHARACTERISTICS:

Age:

  • 18 and over

Other:

  • No other prior or concurrent malignancy within the past 5 years except superficial squamous cell or basal cell skin cancer or carcinoma in situ of the cervix
  • Not pregnant or nursing
  • Negative pregnancy test
  • Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:

Surgery:

  • No prohibitive scars/adhesions from prior abdominal surgery

Other:

  • No concurrent investigational treatments or invasive diagnostic procedures within 30 days after surgery

Treatment and study plan

conventional surgery

Procedure

Laparoscopic surgery

Procedure

Primary outcomes

  1. Disease-free survival

    Time frame: Up to 8 years

    • Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy.
    • Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients.
    • Compare the differences in costs and cost effectiveness between these treatments in this patient population.
    • Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99)
  2. Overall survival

    Time frame: Up to 8 years

Secondary outcomes

  1. Morbidity

    Time frame: Up to 8 years

  2. Mortality

    Time frame: At 30 days

  3. Costs and cost effectiveness between these treatments in this patient population

    Time frame: Up to 8 years

  4. Compare the differences in quality of life of patients treated with these regimens

    Time frame: Up to 8 years

Sponsors and collaborators

Lead sponsor

Alliance for Clinical Trials in Oncology

Other

Collaborators

  • NCIC Clinical Trials Group
  • National Cancer Institute (NCI)

Registry information

Official study title

A PHASE III PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC-ASSISTED COLECTOMY VERSUS OPEN COLECTOMY FOR COLON CANCER

Important dates

Study start
1994
Primary completion
2004
Study completion
2009
First posted
Apr 10, 2003
Registry last updated
Jul 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.